Verano Holdings (VRNO) Free Cash Flow (2021 - 2026)
Verano Holdings' (VRNO) quarterly Free Cash Flow came in at $3.6 million in Q1 2026, up 130.22% year-on-year from $1.6 million in Q1 2025, and down 16.69% on a QoQ basis from $4.4 million in Q4 2025.
Verano Holdings (VRNO) Free Cash Flow (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Free Cash Flow data on file, last reported at $3.6 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 130.22% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $27.4 million, a 234.94% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, down 11.55% from the prior year.
- Free Cash Flow for Q1 2026 stood at $3.6 million, down from $4.4 million in the prior quarter.
- Over the last five years, Free Cash Flow for VRNO reached as high as $132.7 million in Q4 2022 and fell as low as -$84.8 million in Q3 2022.
- Historically, Free Cash Flow has averaged $13.0 million across 5 years, with a median of $8.3 million in 2023.
- On a YoY basis, Free Cash Flow climbed as much as 869.39% in 2022 and fell as far as 358.0% in 2022.
- Year by year, Free Cash Flow stood at $132.7 million in 2022, then plunged by 59.37% to $53.9 million in 2023, then sank by 45.76% to $29.3 million in 2024, then tumbled by 85.03% to $4.4 million in 2025, then declined by 16.69% to $3.6 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $3.6 million in Q1 2026, $4.4 million in Q4 2025, and $18.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.65 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | 431,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Mar 31, 2025 | -12.08 Mn |
| Mar 31, 2025 | -12.08 Mn |
| Dec 31, 2024 | 29.26 Mn |
| Dec 31, 2024 | 29.26 Mn |
| Sep 30, 2024 | -26.86 Mn |
| Sep 30, 2024 | -26.86 Mn |
| Jun 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | -10.60 Mn |
| Mar 31, 2024 | 21.34 Mn |
| Mar 31, 2024 | 21.34 Mn |
| Dec 31, 2023 | 53.94 Mn |
| Dec 31, 2023 | 53.94 Mn |